NDC 43598-854

Deferasirox

Deferasirox

Deferasirox is a Oral Tablet, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Dr. Reddy's Laboratories Inc. The primary component is Deferasirox.

Product ID43598-854_14268314-8e82-c549-1a8d-646b79d30e43
NDC43598-854
Product TypeHuman Prescription Drug
Proprietary NameDeferasirox
Generic NameDeferasirox
Dosage FormTablet, For Suspension
Route of AdministrationORAL
Marketing Start Date2019-11-20
Marketing CategoryANDA / ANDA
Application NumberANDA209878
Labeler NameDr. Reddy's Laboratories Inc
Substance NameDEFERASIROX
Active Ingredient Strength500 mg/1
Pharm ClassesIron Chelating Activity [MoA],Iron Chelator [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 43598-854-05

500 TABLET, FOR SUSPENSION in 1 BOTTLE (43598-854-05)
Marketing Start Date2019-11-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43598-854-05 [43598085405]

Deferasirox TABLET, FOR SUSPENSION
Marketing CategoryANDA
Application NumberANDA209878
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-11-20

NDC 43598-854-90 [43598085490]

Deferasirox TABLET, FOR SUSPENSION
Marketing CategoryANDA
Application NumberANDA209878
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-11-20

NDC 43598-854-30 [43598085430]

Deferasirox TABLET, FOR SUSPENSION
Marketing CategoryANDA
Application NumberANDA209878
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-11-20

Drug Details

Active Ingredients

IngredientStrength
DEFERASIROX500 mg/1

Pharmacological Class

  • Iron Chelating Activity [MoA]
  • Iron Chelator [EPC]
  • Cytochrome P450 3A4 Inducers [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • Cytochrome P450 1A2 Inhibitors [MoA]
  • Iron Chelating Activity [MoA]
  • Iron Chelator [EPC]
  • Cytochrome P450 3A4 Inducers [MoA]
  • Cytochrome P450 2C8 Inhibitors [MoA]
  • Cytochrome P450 1A2 Inhibitors [MoA]

NDC Crossover Matching brand name "Deferasirox" or generic name "Deferasirox"

NDCBrand NameGeneric Name
45963-454DeferasiroxDeferasirox
45963-456DeferasiroxDeferasirox
45963-455DeferasiroxDeferasirox
46708-326DeferasiroxDeferasirox
46708-410DEFERASIROXDEFERASIROX
46708-325DeferasiroxDeferasirox
46708-324DeferasiroxDeferasirox
46708-412DEFERASIROXDEFERASIROX
62332-326DeferasiroxDeferasirox
62332-324DeferasiroxDeferasirox
62332-325DeferasiroxDeferasirox
62332-410DEFERASIROXDEFERASIROX
62332-412DEFERASIROXDEFERASIROX
67877-551DeferasiroxDeferasirox
67877-550DeferasiroxDeferasirox
67877-549DeferasiroxDeferasirox
69539-023DeferasiroxDeferasirox
69539-073DeferasiroxDeferasirox
69539-022DeferasiroxDeferasirox
69539-075DeferasiroxDeferasirox
69539-021DeferasiroxDeferasirox
70710-1277deferasiroxdeferasirox
70710-1275deferasiroxdeferasirox
43598-851DeferasiroxDeferasirox
43598-855DeferasiroxDeferasirox
43598-856DeferasiroxDeferasirox
43598-853DeferasiroxDeferasirox
43598-854DeferasiroxDeferasirox
62756-569deferasiroxdeferasirox
62756-570deferasiroxdeferasirox
62756-568deferasiroxdeferasirox
69452-159DeferasiroxDeferasirox
69452-161DeferasiroxDeferasirox
69452-160DeferasiroxDeferasirox
70771-1471deferasiroxdeferasirox
70771-1473deferasiroxdeferasirox
0093-3515DeferasiroxDeferasirox
0093-3517DeferasiroxDeferasirox
0591-3853DeferasiroxDeferasirox
16714-995deferasiroxdeferasirox
16714-993deferasiroxdeferasirox
0078-0468Exjadedeferasirox
0078-0469Exjadedeferasirox
0078-0470Exjadedeferasirox
0078-0654Jadenudeferasirox
0078-0655Jadenudeferasirox
0078-0656Jadenudeferasirox
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.